Licochalcone D Inhibits Skin Epidermal Cells Transformation through the Regulation of AKT Signaling Pathways
10.4062/biomolther.2023.162
- Author:
Sun-Young HWANG
1
;
Kwanhwan WI
;
Goo YOON
;
Cheol-Jung LEE
;
Soong-In LEE
;
Jong-gil JUNG
;
Hyun-Woo JEONG
;
Jeong-Sang KIM
;
Chan-Heon CHOI
;
Chang-Su NA
;
Jung-Hyun SHIM
;
Mee-Hyun LEE
Author Information
1. College of Korean Medicine, Dongshin University, Naju 58245, Republic of Korea
- Publication Type:Original Article
- From:Biomolecules & Therapeutics
2023;31(6):682-691
- CountryRepublic of Korea
- Language:English
-
Abstract:
Cell transformation induced by epidermal growth factor (EGF) and 12-O-tetradecanoylphorbol-13-acetate (TPA) is a critical event in cancer initiation and progression, and understanding the underlying mechanisms is essential for the development of new therapeutic strategies. Licorice extract contains various bioactive compounds, which have been reported to have anticancer and anti-inflammatory effects. This study investigated the cancer preventive efficacy of licochalcone D (LicoD), a chalcone derivative in licorice extract, in EGF and TPA-induced transformed skin keratinocyte cells. LicoD effectively suppressed EGF-induced cell proliferation and anchorage-independent colony growth. EGF and TPA promoted the S phase of cell cycle, while LicoD treatment caused G1 phase arrest and down-regulated cyclin D1 and up-regulated p21 expression associated with the G1 phase. LicoD also induced apoptosis and increased apoptosis-related proteins such as cleaved-caspase-3, cleaved-caspase-7, and Bax (Bcl-2-associated X protein). We further investigated the effect of LicoD on the AKT signaling pathway involved in various cellular processes and found decreased p-AKT, p-GSK3β, and p-NFκB expression. Treatment with MK-2206, an AKT pharmacological inhibitor, suppressed EGF-induced cell proliferation and transformed colony growth. In conclusion, this study demonstrated the potential of LicoD as a preventive agent for skin carcinogenesis.
